Transfer of hematopoietic stem cells encoding autoantigen autoanfigen prevents autoimmune diabetes

Journal of Clinical Investigation

Volumn 111, Issue 9, 2003, Pages 1357-1363

  Steptoe, Raymond J ^a   Ritchie, Janine M ^a   Harrison, Leonard C ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROINSULIN;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW TRANSPLANTATION; CELL DESTRUCTION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENE TRANSFER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; ISOGRAFT; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SAFETY; T LYMPHOCYTE; TRANSGENICS;

EID: 0038326717     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI15995     Document Type: Article

References (42)

1. Burt, R.K., Slavin, S., Burns, W.H., and Matmont A.M. 2002. Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure? Blood. 99:768-784.
2. Ikehara, S., et al. 1985. Prevention of type 1 diabetes in nonobese diabetic mice by allogeneic bone marrow transplantation. Proc. Natl. Acad. Sci. U. S. A 82:7743-7747.
3. LaFace, D.M., and Peck, A.B. 1989. Reciprocal allogeneic bone marrow transplantation between NOD mice and diabetes-nonsusceptible mice associated with transfer and prevention of autoimmune diabetes. Diabetes. 38:894-901.
4. El-Badri, N.S., et al. 2000. Successful prevention of autoimmune disease by transplantation of adequate number of fully altogeneic hematopoietic stem cells. Transplantation. 70:870-877.
5. Himeno, K., and Good, R.A. 1988. Marrow transplantation from tolerant donors to treat and prevent autoimmune diseases in BXSB mice. Proc. Natl. Acad. Sci U. S. A. 85:2235-2239.
6. Kirzner, R.P., Engelman, R.W., Mizutani, H., Specter, S., and Good, R.A. 2000. Prevention of coronary vascular disease by transplantation of T-cell-depleted bone marrow and hematopoietic stem cell preparation in autoimmune-prone w/BF(1) mice. Biol. Blood Marrow Transplant. 6:513-522.
7. Li, H., et al. 1996. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice. J. Immunol. 156:380-388.
8. Kaufman, C.L., Li, H., and Ildstad, S.T. 1997. Patterns of hemopoietic reconstitution in nonobese diabetic mice: dichotomy of allogeneic resistance versus competitive advantage of disease-resistant marrow. J. Immunol. 158:2435-2442.
9. Castro-Malaspina, H., et al. 2002. Unrelated donot marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program. Blood. 99:1943-1951.
10. Ratanatharathorn, V., Ayash, L., Lazarus, H.M., Fu, J., and Uberti, J.P. 2001. Chronic graft-versus-host disease: clinical manifestation and therapy. Bone Marrow Transplant. 28:121-129.
11. Eynon, E.E., and Parker, D.C. 1992. Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J. Exp. Med. 175:131-138.
12. Niimi, M., Hara, M., Witzke, O., Morris, P.J., and Wood, K.J. 1998 Donor resting B cells induce indefinite prolongation of fuUy allogeneic cardiac grafts when delivered with anti-immunoglobulin-D monoclonal antibody: evidence for tolerogenicity of donor resting B cells in vivo. Transplantation. 66:1786-1792.
13. Finkelman, F.D., Lees, A., Birnbaum, R, Gause, W.C., and Morris, S.C. 1996. Dendritic cells can present antigen in vivo in either a tolerogenic or immunogenic fashion. J. Immunol. 157:1406-1414.
14. Hawiger, D., et al. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194:769-779.
15. Wegmann, D.R., and Eisenbarth, G.S. 2000. It's insulin. J. Autoimmun. 15:286-291.
16. Hänninen, A., and Harrison, L.C. 2000. Gamma delta T cells as mediators of mucosal tolerance: the autoimmune diabetes model. Immunol. Rev. 173:109-119.
17. Narendran, P., Manneting, S., and Harrison, L.C. 2003. Proinsulin - a pathogenic autoantigen in type 1 diabetes. Autoimmun. Rev. In press.
18. French, M.B., et al. 1997. Transgenic expression of mouse proinsulin 11 prevents diabetes in nonobese diabetic mice. Diabetes. 46:34-39.
19. Steptoe, R.J., Ritchie, J.M., and Harrison, L.C. 2002. Increased generation of dendritic cells from myetoid progenitors in autoimmune-prone nonobese diabetic mice. J. Immunol. 168:5032-5041.
20. Leiter, E.H. 1982. Multiple low-dose streptozorocin-induced hyperglycemia and insulitis in C57BL mice: influence of inbred background, sex and thymus. Proc. Natl. Acad. Sci. U. S. A. 79:630-634.
21. Daniel, D., Gill, R.G., Schloot, N., and Wegmann, D. 1995. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol. 25:1056-1062.
22. Chen, W., et al. 2001. Evidence that a peptide spanning the B-C junction of proinsulin is an early autoantigen epitope in the pathogenesis of type 1 diabetes. J. Immunol. 167:4926-4935.
23. Bonifacio, E., et al. 2001. International Workshop on Lessons from Animal Models for Human Type 1 Diabetes: Identification of insulin but nor glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice. Diabetes. 50:2451-2458.
24. Prochazka, M., Gaskins, H.R., Shultz, L.D., and Leiter, E.H. 1992. The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proc. Natl. Acad. Sci. U. S. A. 89:3290-3294.
25. Shultz, L.D., et al. 2000. NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells. J. Immunol. 164:2496-2507.
26. Serreze, D.V., Leiter, E.H., Worthen, S.M., and Shultz, L.D. 1988. NOD marrow stem cells adoptively transfer diabetes to resistant (NOD x NON) F1 mice. Diabetes. 37:252-255.
27. Wicker, L.S., Miller, B.J., Chai, A., Terada, M., and Mullen, Y. 1988. Expression of genetically determined diabetes and insulitis in the nonobese diabetic (NOD) mouse at the level of bone marrow-derived cells, transfer of diabetes and insulitis to nondiabetic (NOD x B10) F1 mice with bone marrow cells from NOD mice. J. Exp. Med. 167:1801-1810.
28. Mathieu, C., Bouillon, R, Rurgeerts, O., and Waer, M. 1995. Induction of mixed bone marrow chimerism as potential therapy for autoimmune (type I) diabetes: experience in the NOD model. Transplant. Proc. 27:640-641.
29. Rudy, G., et al. 1995. Similar peptides from two beta cell autoantigens, proinsulin and glummic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Mol. Med. 1:625-633.
30. Congia, M., Patel, S., Cope, A.P., De Virgilis, S., and Sonderstrup, G. 1998. T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulin. Proc. Natl. Acad. Sci. U. S. A. 95:3833-3838.
31. Durinovic-Bello, I. Boehm, B., and Ziegler, A.-G. 2002. Predominantly recognised proinsulin T helper cell epitopes in individuals with and without islet cell autoimmunity. J. Autoimmun. 18:55-66.
32. Martinez, N.R., et al. 2003. Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide. J. Clin. Invest. 111:1365-1371. doi:10.1172/JCI200317166.
33. Garza, K.M., et al. 2000. Role of antigen-presenting cells in mediating tolerance and aumimmunity. J. Exp. Med. 191:2021-2027.
34. Frazet, I.H., et al. 2001. Tolerance or immunity to a tumor antigen expressed in somatic cells can be determined by systemic ptoinflammatory signals at the time of first antigen exposure. J. Immunol 167:6180-6187.
35. Brocker, T., Riedinger, M., and Karjalainen, K. 1997. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J. Exp. Med. 185:541-550.
36. Kaufman, D.L., et al. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature. 366:69-72.
37. Tisch, R., et al. 1993. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature. 366:72-75.
38. st International NOD Mouse T-cell Workshop and the follow-up Mini-Workshop. Diabetes. 50:2459-2463.
39. Abiru, N., et al. 2001. Transient insulin autoantibody expression independent of development of diabetes: comparison of NOD and NOR strains. J. Autoimmun. 17:1-6.
40. Harrison, L.C. 2001. Risk assessment, prediction and prevention of type 1 diabetes. Pediatr. Diabetes 2:71-82.
41. Rao, S., et al. 1997. Stem cell transplantation in the normal nonmyeloablated host: relationship between cell dose, schedule and engraftment. Exp. Hematol. 25:114-121.
42. Cui, Y., et al. 2002. Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced human hematopoietic stem/progenitor cells. Blood. 99:399-408.